Forte Biosciences (FBRX) Financial Statements

328 Followers

Forte Biosciences Financial Overview

Forte Biosciences's market cap is currently $612.95M. The company's EPS TTM is $-1.39; its P/E ratio is -40.48; Forte Biosciences is scheduled to report earnings on March 31, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Mar 26	Mar 25	Dec 23	Dec 22	Dec 21
Income Statement
Total Revenue	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ 0.00	$ -39.00K	$ -9.00K	$ 0.00	$ -36.00K
Operating Income	$ -70.66M	$ -36.60M	$ -32.49M	$ -13.90M	$ -21.49M
EBITDA	$ -70.59M	$ -35.44M	$ -32.48M	$ -13.86M	$ -21.45M
Net Income	$ -69.38M	$ -35.48M	$ -31.48M	$ -13.86M	$ -21.71M
Balance Sheet
Cash & Short-Term Investments	$ 76.96M	$ 58.37M	$ 37.13M	$ 41.10M	$ 42.04M
Total Assets	$ 82.78M	$ 61.56M	$ 38.98M	$ 42.00M	$ 43.31M
Total Debt	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Net Debt	$ -76.96M	$ -22.24M	$ -11.96M	$ -41.10M	$ -42.04M
Total Liabilities	$ 21.79M	$ 9.08M	$ 3.67M	$ 3.18M	$ 1.76M
Stockholders' Equity	$ 60.99M	$ 52.48M	$ 35.31M	$ 38.82M	$ 41.55M
Cash Flow
Free Cash Flow	$ -51.00M	$ -30.78M	$ -28.79M	$ -8.19M	$ -16.68M
Operating Cash Flow	$ -50.88M	$ -30.75M	$ -28.71M	$ -8.19M	$ -16.68M
Investing Cash Flow	$ 36.23M	$ -35.99M	$ 47.00K	$ 0.00	$ 0.00
Financing Cash Flow	$ 69.36M	$ 51.86M	$ 24.68M	$ 7.24M	$ -44.00K

Currency in USD

Forte Biosciences Earnings and Revenue History

Income Statement >

Forte Biosciences Debt to Assets

Balance Sheet >

Forte Biosciences Cash Flow

Cash Flow >

Forte Biosciences Forecast EPS vs Actual EPS

Earnings >